CSNK1A1 and Miyoshi myopathy: We have also evaluated the absolute transcript levels of CSNK1A1 in 17 symptomatic MM and 2 primary PCL patients, included in GSE66293 proprietary dataset [31], investigated at diagnosis and first relapse.